Longevity & AgingÜbersichtsartikelKostenpflichtig

Lifestyle Interventions Show No Clear Effect on Epigenetic Aging Clocks in Randomized Trials

A meta-analysis of 8 randomized trials finds no statistically significant slowing of DNA methylation aging from exercise, diet, or multidomain lifestyle programs.

Dienstag, 17. November 2026 0 Aufrufe
Veröffentlicht in Arch Gerontol Geriatr
a lab technician loading DNA samples into a sequencing machine beside a printed epigenetic age report

Zusammenfassung

Epigenetic clocks, which estimate biological age from DNA chemical tags, are often used to test whether anti-aging strategies work. This review pooled randomized trials of exercise, diet, calorie restriction, and combined lifestyle programs in adults averaging 45 or older. Eight trials with 1,675 participants were analyzed. None of the clock types showed a statistically significant slowing of aging. The two largest trials found essentially no effect, while the more favorable results came from smaller studies. A small benefit on clocks that predict mortality risk could not be ruled out. The certainty of the evidence was low to very low. The authors call for larger, well-powered trials that name one primary clock in advance and report results in a standardized way. Healthy habits still matter for many outcomes, but this evidence does not show they measurably slow these particular clocks.

Detaillierte Zusammenfassung

Epigenetic clocks have become popular stand-ins for biological aging. Researchers and consumers increasingly use them to judge whether diet, exercise, or other habits are turning back the clock. If lifestyle changes truly slow these clocks, they could serve as fast endpoints for longevity trials. Yet randomized evidence in middle-aged and older adults has been scarce.

This prospectively registered systematic review followed PRISMA 2020 guidelines. The authors searched four major databases and two trial registers for randomized controlled trials of exercise, diet, caloric restriction, or multidomain lifestyle interventions in adults with a mean age of at least 45. Trials had to report a validated DNA methylation clock. Because clocks measure different things, results were pooled separately for chronological-age clocks, phenotypic and mortality clocks, and pace-of-aging measures such as DunedinPACE.

Nine trials were included, and eight, with 1,675 participants and 27 clock-level estimates, were pooled. Chronological-age clocks showed no significant effect (SMD -0.04, 95% CI -0.31 to 0.24). Phenotypic and mortality clocks leaned slightly favorable but were not significant (-0.17, -0.42 to 0.09). DunedinPACE was essentially flat (-0.01, -0.17 to 0.15). The two largest trials were centered on zero, and the favorable estimates came from smaller trials, a pattern that often signals inflated effects. Using one clock per trial gave -0.26 (-0.57 to 0.06), still not significant. Certainty was low to very low.

The findings suggest that current randomized evidence cannot confirm that lifestyle programs slow epigenetic aging. A small effect on phenotypic and mortality clocks remains possible. For clinicians, epigenetic clock changes should be interpreted cautiously as individual-level evidence of intervention success, and lifestyle advice should rest on established clinical outcomes.

Caveats include the small number of trials, heterogeneity in interventions and clocks, and low certainty ratings. This summary is based only on the abstract. Adequately powered trials with pre-specified primary clocks are needed.

Wichtigste Erkenntnisse

  • Pooled data from 8 RCTs (1,675 participants) showed no significant effect of lifestyle interventions on chronological-age DNAm clocks (SMD -0.04).
  • Phenotypic/mortality clocks trended favorable (SMD -0.17) but the confidence interval crossed zero, so a small effect cannot be excluded.
  • DunedinPACE pace-of-aging showed essentially no change (SMD -0.01, 95% CI -0.17 to 0.15).
  • The two largest trials were centered on null; favorable results came from smaller trials, suggesting possible small-study effects.
  • Evidence certainty by GRADE was low to very low, and the authors call for larger trials with a pre-specified primary clock.

Methodik

Prospectively registered systematic review and meta-analysis following PRISMA 2020, searching PubMed, Web of Science, Scopus, CENTRAL, and two trial registers. Three-level models with cluster-robust inference pooled SMDs separately by clock type, and GRADE rated certainty. Eight RCTs in adults with mean age 45 or older were pooled.

Studienlimitierungen

The summary is based on the abstract only, so details of individual trials, interventions, and subgroup analyses were not available. Only a few trials were pooled, with varied interventions and clocks, and certainty was low to very low. Small studies may have inflated favorable estimates, and the review cannot rule out a modest effect on phenotypic/mortality clocks.

Hat dir diese Zusammenfassung gefallen?

Erhalte die neueste Longevity-Forschung jede Woche in deinen Posteingang.

E-Mail-Adresse zum Abonnieren eingeben: